AllianceBernstein Holding L.P. is a publicly owned investment manager. The firm is a related adviser The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fxed-income securities, commodities, currencies, real estate-related assets and infation-protected securities. The firm employs quantitative analysis along with long-term purchases, short-term purchases, trading, short sales, margin transactions, option strategies including writing covered options, uncovered options and spread strategies to make its investments. The firm obtains external research to complement its in-house research. The firm was formerly known as Alliance Capital Management Holding LP. AllianceBernstein Holding L.P. was founded in 1967 and is based in Nashville,Tennessee.

AllianceBernstein Holding L.P. Units

Insiders have been trading these 5 stocks: (($CAVA)), (($AAOI)), (($ELV)), (($INOD)) and (($ABAT)). Here is a breakdown of their recent trades and ...

CAVA, Applied Optoelectronics, Elevance, Innodata, American Battery Shock

DraftKings ( ($DKNG) ) has fallen by -8.34%. Read on to learn why. DraftKings shares slid 8.34% over the past week, even as the company rode a wave...

DraftKings Stock Slumps as Prediction Boom Meets Reality

Insiders have been trading these 5 stocks: (($ENPH)), (($ABT)), (($AXP)), (($LOW)) and (($BE)). Here is a breakdown of their recent trades and thei...

Enphase, Abbott, AmEx, Lowe’s, Bloom: Insider Shockwaves

Healthcare stocks are in focus this month as investors look for steady growth and clear catalysts in a market dealing with volatility and uneven se...

3 Best Healthcare Stocks to Buy in June, According to Analysts

Shares in biotechnology company Apogee Therapeutics ($APGE) are set to start the new week off in great shape on reports that it could be swallowed ...

M&A News: AbbVie Lining up an $11B Deal for Eczema Drug Maker Apogee Therapeutics

Abitare In SpA ( ($IT:ABT) ) just unveiled an announcement. Abitare In S.p.A., the Milan-focused residential developer known for its urban regenera...

Abitare In Calls Ordinary Shareholders’ Meeting for July 20, 2026

VA Tech Wabag Limited ( ($IN:WABAG) ) just unveiled an announcement. VA Tech Wabag has disclosed that it received an order from the Principal Commi...

VA Tech Wabag to Appeal GST Order Upholding ₹6.47 Crore Tax Demand

The latest update is out from VA Tech Wabag Limited ( ($IN:WABAG) ). VA Tech Wabag has allotted 39,113 equity shares of INR 2 each to employees who...

VA Tech Wabag boosts equity capital with ESOP share allotment

VA Tech Wabag Limited ( ($IN:WABAG) ) has shared an update. VA Tech Wabag has received a favourable rectification order from the Uttar Pradesh GST ...

VA Tech Wabag GST Demand Slashed After Favourable Rectification Order

The latest announcement is out from Mortgage Advice Bureau (Holdings) ( ($GB:MAB1) ). Mortgage Advice Bureau has disclosed that senior executives B...

Mortgage Advice Bureau Executives Increase Stakes via Share Incentive Plan

Citi analyst Martin Wilkie maintained a Hold rating on ABB Ltd yesterday. The company’s shares closed yesterday at CHF86.86. According to TipRanks,...

Citi Sticks to Its Hold Rating for ABB Ltd (0NX2)

Tabcorp Holdings Limited ( ($AU:TAH) ) has issued an announcement. Mitsubishi UFJ Financial Group, Inc. has lodged a regulatory notice indicating i...

Mitsubishi UFJ exits substantial holder status in Tabcorp

VA Tech Wabag Limited ( ($IN:WABAG) ) has shared an announcement. VA Tech Wabag has won a design-build-operate contract from Kuwait’s Ministry of E...

Wabag Wins Mega SWRO Desalination Contract in Kuwait, Enters New GCC Market

The latest update is out from SAB Biotherapeutics ( ($SABS) ). On June 18, 2026, SAB Biotherapeutics held its 2026 Annual Meeting of Stockholders, ...

SAB Biotherapeutics Shareholders Back Board and Auditor

An announcement from OmniAb ( ($OABI) ) is now available. OmniAb, Inc. held its 2026 Annual Meeting of Shareholders on June 17, 2026, where investo...

OmniAb Shareholders Approve Directors and Auditor at Meeting

The latest announcement is out from Alibaba ( ($BABA) ). Alibaba Group Holding Limited has adjusted the conversion terms on its convertible senior ...

Alibaba adjusts conversion terms on 2031 convertible notes after 2026 dividend

Grab ($GRAB), Pony.ai ($PONY), and Hillman Solutions ($HLMN) each offers exposure to fast‑growing tech themes, such as ride hailing, autonomous dri...

3 Best Cheap Stocks Under $10 to Consider Now, According to Analysts

Abitare In SpA ( ($IT:ABT) ) has issued an update. Abitare In’s board has convened an ordinary shareholders’ meeting for 20 July 2026 to seek a non...

Abitare In Calls July Shareholders’ Meeting on Proposed Subsidiary Sale to Techbau

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Amylyx Pharmaceuticals Inc (AMLX) ...

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Amylyx Pharmaceuticals Inc (AMLX) and AbCellera Biologics (ABCL)

The latest update is out from Abacus Property Group ( ($AU:ABG) ). Abacus Group has declared a six-month distribution of AUD 0.0425 per fully paid ...

Abacus Group Declares Half-Year Distribution for June 2026 Period

In a report released yesterday, Ian S. Moore from Bernstein maintained a Buy rating on DraftKings, with a price target of $31.00. The company’s sha...

Bernstein Sticks to Their Buy Rating for DraftKings (DKNG)

Ord Minnett analyst maintained a Hold rating on Sonic Healthcare Limited today and set a price target of A$21.30. In addition to Ord Minnett, Sonic...

Ord Minnett Sticks to Their Hold Rating for Sonic Healthcare Limited (SHL)

An update from National Australia Bank Limited ( ($AU:NAB) ) is now available. National Australia Bank has disclosed a change in the interests of d...

NAB updates market on Director Ann Sherry’s securities holdings

Articore Group Limited ( ($AU:ATG) ) just unveiled an update. Articore Group Limited has provided an updated notification to the ASX on its ongoing...

Articore Continues Daily On‑Market Share Buy-Back

Zai Lab ( ($ZLAB) ) has shared an announcement. On June 17, 2026, Zai Lab Limited held its 2026 Annual General Meeting of Shareholders, with holder...

Zai Lab Shareholders Approve Directors, Auditors and Mandates

AbCellera Biologics ( ($ABCL) ) has issued an update. On June 17, 2026, Jazz Pharmaceuticals and AbCellera Biologics announced a preclinical resear...

AbCellera, Jazz Partner on Next-Generation Cancer Antibodies

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is running a late-stage cancer study called “An Open-Label, Randomized, ...

AbbVie’s New Phase 3 Colorectal Cancer Trial Puts ABBV-400 in the Late-Stage Spotlight

The latest update is out from Genmab ( ($GMAB) ). On June 17, 2026, Genmab A/S filed a Form 6-K with the U.S. Securities and Exchange Commission, f...

Genmab Updates Articles of Association, Extends Capital-Raising Powers

An update from National Australia Bank Limited ( ($AU:NAB) ) is now available. National Australia Bank has announced the next quarterly distributio...

NAB Sets September 2026 Distribution Rate for Capital Notes 5

National Australia Bank Limited ( ($AU:NAB) ) has shared an announcement. National Australia Bank has set the next quarterly distribution on its NA...

NAB Sets September 2026 Distribution for Capital Notes 6

An announcement from National Australia Bank Limited ( ($AU:NAB) ) is now available. National Australia Bank Limited has announced a quarterly full...

NAB Sets September 2026 Distribution for Capital Notes 8

The latest announcement is out from National Australia Bank Limited ( ($AU:NAB) ). National Australia Bank has announced a quarterly distribution f...

NAB sets September 2026 distribution for Capital Notes 7

The latest update is out from National Australia Bank Limited ( ($AU:NAB) ). National Australia Bank Limited and associated entities have notified ...

NAB ceases to be substantial holder in Spenda after share issue dilutes stake

The latest announcement is out from Lindab International AB ( ($SE:LIAB) ). Lindab Group has completed the divestment of its Romanian operations, f...

Lindab completes Romanian divestment, finalises Eastern Europe exit

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ryman Healthcare (RHCGF) and SAB Biotherapeutics (SA...

Analysts Are Bullish on Top Healthcare Stocks: Ryman Healthcare (RHCGF), SAB Biotherapeutics (SABS)

National Australia Bank Limited ( ($AU:NAB) ) has provided an announcement. National Australia Bank Limited has redeemed all 18,740,582 of its NABP...

National Australia Bank Redeems Entire NABPF Capital Note Issue

National Australia Bank Limited ( ($AU:NAB) ) has provided an announcement. National Australia Bank Limited has completed the redemption of all out...

NAB Redeems All Outstanding NAB Capital Notes 3

ABx Group Limited ( ($AU:ABX) ) has issued an update. ABx Group has reported that a second mixed rare earth carbonate sample from its Deep Leads pr...

ABx Group’s Low-Radioactivity Rare Earth Carbonate Wins Strong Customer Interest

Articore Group Limited ( ($AU:ATG) ) just unveiled an announcement. Articore Group Limited, traded on the ASX as ATG, is an Australian listed compa...

Articore Group Continues Daily On‑Market Share Buy‑Back

In a report released yesterday, Liam Robertson from Jarden maintained a Hold rating on Aussie Broadband Ltd., with a price target of A$5.50. The co...

Jarden Keeps Their Hold Rating on Aussie Broadband Ltd. (ABB)

In a report released today, Cameron Bell from Canaccord Genuity maintained a Buy rating on Aussie Broadband Ltd., with a price target of A$6.87. Ac...

Canaccord Genuity Sticks to Their Buy Rating for Aussie Broadband Ltd. (ABB)

Jarden analyst Steven Wheen maintained a Hold rating on Sonic Healthcare Limited yesterday and set a price target of A$22.30. The company’s shares ...

Jarden Sticks to Their Hold Rating for Sonic Healthcare Limited (SHL)

Genmab ( ($GMAB) ) has shared an announcement. On June 16, 2026, Genmab A/S announced a minor capital increase after employees exercised warrants, ...

Genmab Announces Minor Capital Increase Following Employee Warrant Exercise

In a report released yesterday, Yatin Suneja from Guggenheim reiterated a Buy rating on Abivax SA Sponsored ADR, with a price target of $175.00. Th...

Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Encompass Health (EHC) and Abivax SA Sponsored ADR (...

Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), Abivax SA Sponsored ADR (ABVX)

Barclays analyst Etzer Darout maintained a Buy rating on Abivax SA Sponsored ADR today and set a price target of $148.00. Darout covers the Healthc...

Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Atour Lifestyle Holdings (ATAT), Airbnb (ABNB) and Casey’s...

Analysts Offer Insights on Consumer Cyclical Companies: Atour Lifestyle Holdings (ATAT), Airbnb (ABNB) and Casey’s General (CASY)

In a report released today, Andre Kukhnin from UBS maintained a Hold rating on ABB Ltd, with a price target of CHF69.00. According to TipRanks, Kuk...

UBS Keeps Their Hold Rating on ABB Ltd (0NX2)

UBS analyst Andre Kukhnin maintained a Hold rating on Daimler Truck Holding AG today and set a price target of €46.00. According to TipRanks, Kukhn...

Daimler Truck Holding AG (DTG) Gets a Hold from UBS

Saab AB ( ($SE:SAAB.B) ) has issued an update. Saab has secured a contract from France’s defence procurement agency for its NLAW next-generation li...

Saab Wins French Contract for NLAW Anti-Tank Weapon System

UBS analyst David Low maintained a Hold rating on Sonic Healthcare Limited yesterday and set a price target of A$19.60. Low covers the Healthcare s...

UBS Reaffirms Their Hold Rating on Sonic Healthcare Limited (SHL)

In a report released today, Ian Munro from Ord Minnett maintained a Buy rating on Aussie Broadband Ltd., with a price target of A$6.37. According t...

Ord Minnett Sticks to Its Buy Rating for Aussie Broadband Ltd. (ABB)

UBS analyst William Park CPA maintained a Buy rating on Aussie Broadband Ltd. today and set a price target of A$6.20. According to TipRanks, Park C...

UBS Sticks to Its Buy Rating for Aussie Broadband Ltd. (ABB)

Mesa Laboratories ( ($MLAB) ) has provided an update. On June 11, 2026, Mesa Laboratories, Inc.’s board appointed longtime company executive Lyndse...

Mesa Laboratories Promotes Lyndsey Crennen to Chief Accounting Officer

An announcement from Cencora ( ($COR) ) is now available. On June 15, 2026, Cencora announced that Executive Vice President and Chief Human Resourc...

Cencora announces leadership transition in human resources

The latest update is out from United Parcel ( ($UPS) ). United Parcel Service, Inc. announced that board member Eva Boratto resigned from its Board...

United Parcel board member resigns following external CFO appointment

The latest announcement is out from Genmab ( ($GMAB) ). On June 15, 2026, Genmab A/S filed a Form 6-K with the U.S. Securities and Exchange Commiss...

Genmab Updates Articles of Association to Expand Capital-Raising Flexibility

An update from Genmab ( ($GMAB) ) is now available. Genmab A/S reported in a June 15, 2026 filing with the U.S. Securities and Exchange Commission ...

Genmab Discloses Orbis as New 4.99% Major Shareholder

Consolidation is taking place in the fintech space. 


M&A News: Payoneer Global (PAYO) to be Acquired by Canada’s Nuvei for $2.75 Billion

High prices and a strong job market mean rate cuts will not happen soon, which could cause wide swings in the stock market. Since these trends add ...

5 Powerhouse Dividend Stocks with Huge Cash Payouts to Help Investors Crush Surging Inflation

Trelleborg AB ( ($SE:TREL.B) ) has provided an update. Trelleborg AB has repurchased 97,510 series B shares on Nasdaq Stockholm between June 8 and ...

Trelleborg Advances SEK 2 Billion Share Buyback With New Series B Repurchases

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Halozyme (HALO), SAB Biotherapeutics (SABS) and Design Therapeuti...

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), SAB Biotherapeutics (SABS) and Design Therapeutics (DSGN)

Shares of Nebius Group ($NBIS) were up 8.9% in pre-market trading after the company was added to the Nasdaq-100 Index&nbsp;(NDX). Last week, Nasdaq...

Why Is Nebius Stock (NBIS) Surging Today, 6/15/26?

Goldman Sachs analyst Oliver Carruthers downgraded Aberdeen Group to a Hold today and set a price target of $250.00. Carruthers covers the Financia...

Goldman Sachs downgrades Aberdeen Group (ABDN) to a Hold

Fabege AB ( ($SE:FABG) ) just unveiled an update. Fabege AB has announced that it will publish its interim report for January to July 2026 on 6 Jul...

Fabege to Present Jan–Jul 2026 Interim Results via Audiocast and Call

Alibaba ( ($BABA) ) has been popular among investors this week. Here is a recap of the key news on this stock. Alibaba is deepening its pivot from ...

Alibaba’s AI Bet: Painful Earnings Hit, Huge Upside?

Ameris Bancorp ( ($ABCB) ) has provided an update. On June 12, 2026, a federal jury in the Central District of California found Ameris Bank liable ...

Ameris Bancorp Faces Major Jury Verdict, Plans Appeal

The latest update is out from Cyabra ( ($CYAB) ). On June 9, 2026, Cyabra, Inc. disclosed that it had fallen out of compliance with two Nasdaq Glob...

Cyabra Receives Nasdaq Notice Over Listing Compliance Issues

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is launching a new early-stage trial focused on children with har...

AbbVie Targets Pediatric AML With New Pivekimab Sunirine Trial, Signaling Deeper Oncology Push

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s new study, officially titled “Phase 2/3 Open Label Randomized Study of...

AbbVie Targets Tough Pancreatic Cancer With New Phase 2/3 Telisotuzumab Study

An announcement from AbCellera Biologics ( ($ABCL) ) is now available. AbCellera Biologics Inc. held its Annual Meeting of Shareholders on June 11,...

AbCellera Shareholders Back Directors, Auditors, Executive Pay

BAB ( ($BABB) ) has shared an update. On June 11, 2026, BAB, Inc. announced that Chief Financial Officer and principal financial officer Geraldine ...

BAB CFO Shifts to Part-Time Role, Outsources Support

Shares of cloud infrastructure provider CoreWeave ($CRWV) were up 4.9% in pre-market trading, following news of its inclusion in the Nasdaq-100 Ind...

CoreWeave Stock Forecast – NDX Inclusion, Strong Growth, and Mixed Analyst Views

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Genmab (GMAB), HCA Healthcare (HCA) and Thermo Fishe...

Wall Street Analysts Are Bullish on Top Healthcare Picks

In a report released today, Justin Post from Bank of America Securities maintained a Hold rating on Airbnb, with a price target of $150.00. Post co...

Airbnb (ABNB) Gets a Hold from Bank of America Securities

Wells Fargo analyst Ken Gawrelski maintained a Buy rating on Airbnb yesterday and set a price target of $181.00. The company’s shares closed yester...

Wells Fargo Sticks to Its Buy Rating for Airbnb (ABNB)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on C4 Therapeutics (CCCC), AbbVie (ABBV) and Hinge Heal...

Analysts Are Bullish on These Healthcare Stocks: C4 Therapeutics (CCCC), AbbVie (ABBV)

Alibaba ($BABA) has been going through a painful but important business transition. The company’s earnings have been hit hard by aggressive investm...

Alibaba’s Painful Shift Could Still Reward Patient Investors

Shares of CoreWeave ($CRWV), Nebius ($NBIS), Rocket Lab ($RKLB), Astera Labs ($ALAB), and Teradyne ($TER) rallied in after-hours trading following ...

CRWV, NBIS, RKLB Shares Jump after Nasdaq Adds Stocks to Nasdaq-100 (NDX)

Alphabet Class A ( ($GOOGL) ) has shared an update. Alphabet shareholders, meeting on June 5, 2026, approved an amendment to the 2021 Stock Plan th...

Alphabet Shareholders Approve Stock Plan Expansion, Reelect Board

Genmab ( ($GMAB) ) just unveiled an update. On June 11, 2026, Genmab A/S reported that its board approved the grant of 15,894 restricted stock unit...

Genmab Grants New Restricted Stock Units and Warrants to Employees

Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab (OTC: GMAB) has terminated a Phase 2 study called “Efficacy and Sa...

Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook

Analysts fell to the sidelines weighing in on AllianceBernstein (AB) and W. R. Berkley Corporation (WRB) with neutral ratings, indicating that the ...

Market Cap	$3.61B	P/E Ratio	10.39
52W High	$44.11	52W Low	$35.59
Div Yield	332.0%	Payout Ratio	159.6%
EPS Growth 3Y	3.4%	52W Position	4.2%
Overall Score	70	Value Score	100
Quality Score	65	Technical Score	45

EPS Current Est	$3.46	EPS Next Est	$3.77
EPS Growth Est	+9.0%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AB	$35.95	-0.58%	408.05K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AB	$35.95	-0.6%	408.05K
3
4
5
6

AB

AB

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get AllianceBernstein Holding L.P. Units Data in Excel

Get AllianceBernstein Holding L.P. Units Data in Excel